- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03005457
Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy
December 25, 2016 updated by: Lynne Gauthier , PhD, Ohio State University
A Low-cost Virtual Reality Gaming Platform for Neurorehabilitation of Hemiparesis
Pilot study to assess the feasibility and initial efficacy of therapist-as-consultant, game-based CI therapy.
Pre/post study design.
Participant received a target of 30 hours game-based motor intervention, 100 hours constraint of the less affected upper extremity, and 5 hours therapist consultation (including completion of a behavioral contract at the first study visit).
Duration of intervention was 10 consecutive weekdays, with pre-treatment and post-treatment testing performed within 1 week prior to and 1 week post-intervention by an independent tester.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University, 2154 Dodd Hall
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female aged > 17
- Preserved ability to comprehend English and participate in basic elements of the therapy
- Community-dwelling
- Experienced mild to moderate hemiparesis at least six months prior
- Can independently operate the gaming system (those with severe cognitive impairments can usually achieve this)
- Corrected vision of at least 20/70 as assessed by their ability to identify game objects on the monitor from 5 feet away
Exclusion Criteria:
- concurrent participation in other experimental upper extremity trials
- concurrent participation in other outpatient rehabilitation for their upper extremity
- Botox within the last 3 months (confound)
- near-normal motor function (9-hole Peg Test score above the 10th percentile of a normative sample)
- minimal nonuse (Motor Activity Log at baseline >2.5, Accelerometry > 60%)
- major medical issues that would interfere with study treatments or make intensive rehabilitation difficult to tolerate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stroke
|
An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids
|
|
Experimental: Hemiparesis other
|
An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Motor Activity Log
Time Frame: Week 0 and Week 3
|
Self-report measure of arm use for daily activities
|
Week 0 and Week 3
|
|
Change in Wolf Motor Function Test
Time Frame: Week 0 and Week 3
|
Objective measure of motor function in a laboratory setting
|
Week 0 and Week 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kinematic Data
Time Frame: Week 0 and Week 3
|
Kinematic data recorded during game play
|
Week 0 and Week 3
|
|
Brief Kinesthesia test
Time Frame: Week 0 and Week 3
|
Clinical Assessment of sensation
|
Week 0 and Week 3
|
|
Patient Health Questionnaire
Time Frame: Week 0 and Week 3
|
Measures Depression
|
Week 0 and Week 3
|
|
Strok Specific Quality of Life Scale
Time Frame: Week 0 and Week 3
|
Quality of life measurement
|
Week 0 and Week 3
|
|
Weschler Adult Intelligence Scale Symbol Seach
Time Frame: Week 0 and Week 3
|
Cognitive processing speed assessment
|
Week 0 and Week 3
|
|
Montreal Cognitive Assessment
Time Frame: Week 0 and Week 3
|
Baseline cognitive screen
|
Week 0 and Week 3
|
|
Survey
Time Frame: Week 0 and Week 3
|
Survey on satisfaction with the intervention
|
Week 0 and Week 3
|
|
Mitt Compliance
Time Frame: Week 0 and Week 3
|
Hours of use
|
Week 0 and Week 3
|
|
Total game-play time
Time Frame: Week 0 and Week 3
|
Week 0 and Week 3
|
|
|
Gestures
Time Frame: Week 0 and Week 3
|
Number of gestures of each type registered in game
|
Week 0 and Week 3
|
|
Bilateral activity monitors
Time Frame: Week 0 and Week 3
|
Objective measure of arm use
|
Week 0 and Week 3
|
|
Action Research Arm Test (ARAT)
Time Frame: Week 0 and Week 3
|
Asses Changes in Limb Function
|
Week 0 and Week 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
December 21, 2016
First Submitted That Met QC Criteria
December 25, 2016
First Posted (Estimate)
December 29, 2016
Study Record Updates
Last Update Posted (Estimate)
December 29, 2016
Last Update Submitted That Met QC Criteria
December 25, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60047824
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Will be shared upon publication acceptance.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on Hemiparesis Therapy with VR
-
Riphah International UniversityCompleted
-
Fundació Sant Joan de DéuRecruitingSchizophrenia Disorders | Treatment Resistant HallucinationsSpain
-
Shanghai Mental Health CenterNanjing XR-Oasis Technology Co., Ltd.RecruitingBipolar Disorder | Interventional Study | VRChina
-
Victor H. DuenasMedical University of South Carolina; Eunice Kennedy Shriver National Institute...Completed
-
Thomas More University of Applied SciencesRevalidatieziekenhuis RevArte; To Walk Again REVAlution CenterCompleted
-
National Institute of General Medical Sciences...Completed
-
National Information Processing InstituteCompleted
-
Assuta Ashdod HospitalNot yet recruitingPain | Anxiety | Virtual Reality
-
University of LiegeOncomfort; BiowinCompletedHealthy VolunteersBelgium
-
University of Alabama at BirminghamCompletedStroke | Hemiparesis | Walking, DifficultyUnited States